A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...
Jacksonville Journal-Courier on MSNOpinion
Point & counterpoint: GLP-1: A case for expanding access to weight-loss medications— Alison Sexton Ward
Commentary: Obesity and its related conditions — including diabetes, heart disease, stroke and cancer — are responsible for ...
Injectable GLP-1 receptor agonists show reduced effectiveness in real-world settings due to early discontinuation and low maintenance dosing. Patients maintaining treatment lost more weight, with high ...
Levothyroxine is a lab-made form of thyroid hormone that helps your body access the amount of the hormone it needs. Hypothyroidism has many possible symptoms, including weight gain. Once you're taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results